Patents by Inventor Kenneth Gary

Kenneth Gary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200165422
    Abstract: This disclosure relates to a continuous solution polymerization process wherein production rate is increased. Process solvent, ethylene, optional comonomers, optional hydrogen and a single site catalyst formulation are injected into a first reactor forming a first ethylene interpolymer. Process solvent, ethylene, optional comonomers, optional hydrogen and a heterogeneous catalyst formulation are injected into a second reactor forming a second ethylene interpolymer. The first and second reactors may be configured in series or parallel modes of operation. Optionally, a third ethylene interpolymer is formed in an optional third reactor, wherein an optional heterogeneous catalyst formulation may be employed. In a solution phase, the first, second and optional third ethylene interpolymers are combined, the catalyst is deactivated, the solution is passivated and following a phase separation process an ethylene interpolymer product is recovered.
    Type: Application
    Filed: January 24, 2020
    Publication date: May 28, 2020
    Applicant: NOVA Chemicals (International) S.A.
    Inventors: Fazle Sibtain, Christopher John Brooke Dobbin, Donald Gary Hartlen, Kenneth Edward Taylor, Hamidreza Khakdaman
  • Patent number: 10626256
    Abstract: This disclosure relates to a continuous solution polymerization process wherein production rate is increased. Process solvent, ethylene, optional comonomers, optional hydrogen and a single site catalyst formulation are injected into a first reactor forming a first ethylene interpolymer. Process solvent, ethylene, optional comonomers, optional hydrogen and a heterogeneous catalyst formulation are injected into a second reactor forming a second ethylene interpolymer. The first and second reactors may be configured in series or parallel modes of operation. A third ethylene interpolymer is formed in a third reactor, wherein an optional heterogeneous catalyst formulation may be employed. In a solution phase, the first, second and optional third ethylene interpolymers are combined, the catalyst is deactivated, the solution is passivated and following a phase separation process an ethylene interpolymer product is recovered.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: April 21, 2020
    Assignee: NOVA CHEMICALS (INTERNATIONAL) S.A.
    Inventors: Fazle Sibtain, Christopher John Brooke Dobbin, Donald Gary Hartlen, Kenneth Edward Taylor, Hamidreza Khakdaman
  • Patent number: 10518291
    Abstract: A device and method for applying a material to a surface to repair, restore or refurbish at least a portion of the surface. The device has a sensor and one or more applicator nozzles. The device further includes a reservoir for containing a material to be deposited, and a CPU. The method includes providing information from the sensor about the surface to the CPU, which uses the information to identify where the material is to be deposited and/or how much to deposit.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: December 31, 2019
    Assignee: The Procter & Gamble Company
    Inventors: Stephan Gary Bush, Ted De Castro, Dana Paul Gruenbacher, Kenneth Lee Morand, Thomas Elliot Rabe, Faiz Feisal Sherman, Todd Michael Wernicke
  • Patent number: 10435639
    Abstract: A process for making cerium dioxide nanoparticles containing at least one transition metal (M) utilizes a suspension of cerium hydroxide nanoparticles prepared by mechanical shearing of an aqueous mixture containing an oxidant in an amount effective to enable oxidation of cerous ion to ceric ion, thereby forming a product stream that contains transition metal-containing cerium dioxide nanoparticles, Ce1-xMxO2, wherein “x” has a value from about 0.3 to about 0.8. The nanoparticles thus obtained have a cubic fluorite structure, a mean hydrodynamic diameter in the range of about 1 nm to about 10 nm, and a geometric diameter of less than about 4 nm. The transition metal-containing crystalline cerium dioxide nanoparticles can be used to prepare a dispersion of the particles in a nonpolar medium.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: October 8, 2019
    Assignee: Cerion, LLC
    Inventors: Albert Gary Difrancesco, Thomas D. Allston, Richard K. Hailstone, Andreas Langner, Kenneth J. Reed
  • Publication number: 20190224155
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Application
    Filed: February 27, 2019
    Publication date: July 25, 2019
    Applicant: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Publication number: 20190133977
    Abstract: The present invention relates in certain embodiments to a controlled release formulation, especially a sachet, comprising a unit dosage of a dry powder of tamsulosin or a pharmaceutically acceptable salt thereof in a controlled release matrix and to methods of making and using such formulation. The controlled release formulation is beneficial in the treatment of benign prostatic hyperplasia (BPH), particularly in those patients suffering from dysphagia. The controlled release formulation is easily dispersed in water or other suitable liquid, and so solves the problem of dysphagia, thereby improving patient compliance in that targeted patient population, yet the controlled release formulation has a release profile in a patient on an empty stomach similar to FLOMAX® ((R)-5-(2-{[2-(2-Ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzene-1-sulfonamide hydrochloride) taken 30 minutes after a meal, but does not exhibit the FLOMAX® tablet food effect, thereby improving dosage form administration flexibility.
    Type: Application
    Filed: May 4, 2017
    Publication date: May 9, 2019
    Applicant: ASPEN PARK PHARMACEUTICALS, INC.
    Inventors: K. Gary Barnette, Ruth E. Stevens, Kenneth V. Phelps, Lynn Gold
  • Patent number: 10258590
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: April 16, 2019
    Assignee: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Publication number: 20170238851
    Abstract: Sensor systems, transdermal analyte monitoring systems (TAMS), and methods of improving analyte detection are described herein. The sensor systems have two working terminals, at least one counter terminal, and optionally one or more reference terminals. The first working terminal measures electrical signals due to an analyte level along with background interferences. The second working terminal measures only background interferences. The transdermal analyte monitoring systems include the sensor system and a computing device. The computing device performs mathematical analysis using an appropriate algorithm on the electrical information provided by the electrodes of the sensor system to obtain an accurate analyte level. Typically, the second electrical signal is subtracted from the first electrical signal to obtain an accurate analyte level in real time.
    Type: Application
    Filed: August 26, 2015
    Publication date: August 24, 2017
    Inventors: Eric V. Duhamel, Kenneth Gary
  • Publication number: 20170105903
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Application
    Filed: October 12, 2016
    Publication date: April 20, 2017
    Applicant: ALCRESTA THERAPEUTICS, INC.
    Inventors: Robert GALLOTTO, Greta L. LORING, Kenneth GARY, Edward S. PARK, David J. BROWN, Willem Robert Klaas SCHOEVAART, Michiel Christian Alexander van VLIET
  • Publication number: 20170087321
    Abstract: A neonatal resuscitation mask that achieves an effective seal with a patient's face with minimal application forces. The mask can include a cushion that forms a sealing surface with a patient's face that is made from a soft gel material. The cushion can also include a restriction ring that is capable of limiting radial expansion and collapse of the cushion, when application forces are applied.
    Type: Application
    Filed: March 17, 2015
    Publication date: March 30, 2017
    Inventors: Kenneth Gary JORDAN, Erik Robertus SCHEIRLINCK
  • Publication number: 20120077277
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Application
    Filed: December 6, 2011
    Publication date: March 29, 2012
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 8080205
    Abstract: Analyte meter protectors, meters that include the same, and methods. In one example, a ketone monitoring system is provided wherein a port protector is used in combination with a meter.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: December 20, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Publication number: 20110253532
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Application
    Filed: February 24, 2011
    Publication date: October 20, 2011
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7918426
    Abstract: An adjustable mount for mounting a flat panel display screen on a support comprises a first component adapted for securement to the support and forming a rear of the mount, a second component engaged with the first component and forming a front of the mount to which the screen is intended to be secured, in use, and an adjustment device acting between the first and second components to alter the relative positioning therebetween.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: April 5, 2011
    Assignee: AVF Group Limited
    Inventors: Mark Short, Kenneth Gary Nicholls, Raymond Worrall
  • Patent number: 7914742
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: November 20, 2009
    Date of Patent: March 29, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7897107
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: March 1, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7867446
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: January 11, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7857270
    Abstract: A tilting mechanism comprises a first component intended to mount a flat panel display and a second component intended to be secured to a support. The first component has first and second pivots and the second component has first and second elongated slots into which the first and second pivots respectively are received so that the first component can be moved relative to the second component to adjust, in use, the tilt of the flat panel display. In use, an upper one of the elongated slots extends at an angle upwardly and forwardly of the second component, while the lower one of the elongated slots extends upright or upwardly and rearwardly of the second component.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: December 28, 2010
    Assignee: AVF Group Limited
    Inventors: Mark Short, Kenneth Gary Nicholls, Raymond Worrall
  • Patent number: 7846386
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: December 7, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7846387
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: December 7, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary